Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
10.55 EUR | +22.96% | +25.60% | +147.65% |
02:29pm | Oppenheimer Cuts Nyxoah Price Target to $15 From $20, Maintains Outperform Rating | MT |
14/05 | Transcript : Nyxoah S.A., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.65% | 27Cr | |
+12.06% | 23TCr | |
+12.07% | 19TCr | |
+13.88% | 14TCr | |
+27.12% | 11TCr | |
+0.80% | 6.41TCr | |
+13.39% | 5.21TCr | |
+6.74% | 5.19TCr | |
+8.81% | 4.43TCr | |
+4.14% | 3.68TCr |
- Stock Market
- Equities
- NYXH Stock
- News Nyxoah SA
- Nyxoah, ResMed Germany Team Up to Improve OSA Awareness, Treatment